These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31602702)

  • 1. DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
    Koroknai V; Szász I; Hernandez-Vargas H; Fernandez-Jimenez N; Cuenin C; Herceg Z; Vízkeleti L; Ádány R; Ecsedi S; Balázs M
    Exp Dermatol; 2020 Jan; 29(1):39-50. PubMed ID: 31602702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genomic alterations of invasive melanoma cells].
    Koroknai V
    Magy Onkol; 2022 Oct; 66(3):243-245. PubMed ID: 36200505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
    Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
    Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
    Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
    Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
    Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
    Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A global profile of gene promoter methylation in treatment-naïve urothelial cancer.
    Ibragimova I; Dulaimi E; Slifker MJ; Chen DY; Uzzo RG; Cairns P
    Epigenetics; 2014 May; 9(5):760-73. PubMed ID: 24521710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma.
    Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G
    Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
    Liu S; Ren S; Howell P; Fodstad O; Riker AI
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
    Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.
    Mazar J; Khaitan D; DeBlasio D; Zhong C; Govindarajan SS; Kopanathi S; Zhang S; Ray A; Perera RJ
    PLoS One; 2011; 6(9):e24922. PubMed ID: 21949788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TET2-mediated methylation reconstruction on A2058 melanoma cell sensitivity to matrix stiffness in a 3D culture system.
    Shen Z; Liu Z; Li M; Han L; Wang J; Wu X; Sang S
    Exp Cell Res; 2024 Sep; 442(1):114224. PubMed ID: 39187151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.
    Mezzanotte JJ; Hill V; Schmidt ML; Shinawi T; Tommasi S; Krex D; Schackert G; Pfeifer GP; Latif F; Clark GJ
    Epigenetics; 2014 Nov; 9(11):1496-503. PubMed ID: 25482183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
    Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
    Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
    Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
    Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.
    Lauss M; Haq R; Cirenajwis H; Phung B; Harbst K; Staaf J; Rosengren F; Holm K; Aine M; Jirström K; Borg Å; Busch C; Geisler J; Lønning PE; Ringnér M; Howlin J; Fisher DE; Jönsson G
    J Invest Dermatol; 2015 Jul; 135(7):1820-1828. PubMed ID: 25705847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.